keywords

  • muud tervishoiuteenused

Employees and salaries

BRAVO PHARMACEUTICALS AS

Number of employees and estimated average salaries
?

BRAVO PHARMACEUTICALS AS

Employee taxes and performance analysis
?
QuarterLabor taxes
paid
Number of employees
Turnover
Per Employee
Profit
per employee
2024 I........................
2023 IV........................
2023 III........................
2023 II........................
2023 I........................
2022 IV........................
2022 III........................
2022 II........................
2022 I........................
2021 IV........................
2021 III........................
2021 II........................
2021 I........................
2020 IV........................
2020 III........................
2020 II........................
2020 I........................
2019 IV........................
2019 III........................
2019 II........................
2019 I........................
2018 IV........................
2018 III........................
2018 II........................
2018 I........................
2017 IV........................
2017 III........................
2017 II........................
2017 I........................
2016 IV........................

Deciders and beneficiaries

BRAVO PHARMACEUTICALS AS

Deciders
?
Rakesh Pandey
★★★★

......

Credit Score: Borderline

Reputation scores: 5100

Date of birth: ......

Active relations 3

Reena Singh
★★★★

......

Credit Score: Risky

Reputation scores: 2060

Date of birth: ......

Active relations 1


*Every member of the management board may represent the public limited company in concluding all transactions.

BRAVO PHARMACEUTICALS AS

History of right of representation
?
Health Care
7y
Estonia
 
Reena Singh ... - ...
Rakesh Pandey ... - ...
2016
2017
2018
2019
2021
2022
2023
2024
2016
2017
2018
2019
2020
2021
2022
2023
2024

BRAVO PHARMACEUTICALS AS

Owners
?

Former owners

NameCredit ScorePaymentBeginningTypeHolding
!
..................
20%
0.47
..................
79%

Former owners

NameCredit ScorePaymentBeginningEnd
0.47
..................
!
..................
!
..................
0.47
..................
!
..................
0.47
..................
0.47
..................
0.47
..................

BRAVO PHARMACEUTICALS AS

Other related parties
?

Former other persons

NameCredit ScorePartBeginning
!
............
0.01
............
0.01
............
!
............

Other related parties (invalid relations)

NameCredit ScorePartBeginningEnd
0.16
..................
0.99
..................

BRAVO PHARMACEUTICALS AS

Subsidiaries and associates
?

Former subsidiaries and associates

NameCredit ScorePaymentBeginningTypeHolding
0.01
..................
65%

Former subsidiaries and associates

NameCredit ScorePaymentBeginningEnd
0.01
..................
0.01
..................
0.01
..................

Beneficiaries

Volumes and values ​​of beneficiaries' assets

Finances and assets

BRAVO PHARMACEUTICALS AS

Goodwill

BRAVO PHARMACEUTICALS AS

Paid taxes and estimated average salaries

BRAVO PHARMACEUTICALS AS

The number of days buyers have not paid
?

BRAVO PHARMACEUTICALS AS

Quarterly indicators
QuarterTurnoverTaxed turnoverLabor productivityLabor productivityEmployeesNational taxesLabor taxes
2024 I* ............* ..............................
2023 IV* ............* ..............................
2023 III* ............* ..............................
2023 II* ............* ..............................
2023 I* ............* ..............................
2022 IV* ............* ..............................
2022 III* ............* ..............................
2022 II* ............* ..............................
2022 I* ............* ..............................
2021 IV* ............* ..............................
2021 III* ............* ..............................
2021 II* ............* ..............................
2021 I* ............* ..............................
2020 IV* ............* ..............................
2020 III* ............* ..............................
2020 II* ............* ..............................
2020 I* ............* ..............................
2019 IV* ............* ..............................
2019 III* ............* ..............................
2019 II* ............* ..............................
2019 I* ............* ..............................
2018 IV* ............* ..............................
2018 III* ............* ..............................
2018 II* ............* ..............................
2018 I* ............* ..............................
2017 IV* ............* ..............................
2017 III* ............* ..............................
2017 II* ............* ..............................
2017 I* ............* ..............................

BRAVO PHARMACEUTICALS AS

Sales revenue by business area

BRAVO PHARMACEUTICALS AS

Sales revenue by country

BRAVO PHARMACEUTICALS AS

Financial indicators and prognosis

BRAVO PHARMACEUTICALS AS

Financial raiting: "POOR" (2024 prognosis)
2024 prognosis
LIQUIDITY
?
Net Working capital
...
Short-term debt coverage ratio
...
USE OF LOAN CAPITAL
?
Turnover ratio of fixed assets (X)
...
EFFECTIVENESS
?
Debt to assets ratio (X)
...
Capitalisation multiplier (X)
...
PROFITABILITY
?
Sales revenues (%)
...
Total asset revenues (%)
...
Equity revenues (%)
...
Unsatisfactory
1
2
3
4
5
Very good

BRAVO PHARMACEUTICALS AS

Real estate as of 14.06.2024

Active and unactive real estate

igon V......

BRAVO PHARMACEUTICALS AS

Annual reports
Year Period Submitted Report PDF
2022 01.01.2022–31.12.2022 26.09.2023 ......
2021 01.01.2021–31.12.2021 21.06.2022 ......
2020 01.01.2020–31.12.2020 12.10.2021 ......
2019 01.01.2019–31.12.2019 21.09.2021 ......
2018 01.01.2018–31.12.2018 09.06.2020 ......
2017 01.01.2017–31.12.2017 12.08.2019 ......

Liabilities and debts

BRAVO PHARMACEUTICALS AS

Credit score history and prognosis
Recommended credit limit

... €

Recommended payment term

......

Business risk classes:

Trustworthy Neutral
Borderline Problematic Risky

BRAVO PHARMACEUTICALS AS

Reports and assets-liabilities overview 14.06.2024
?
Annual reports: ......
Annual reports: ......
Tax declarations:......

Assets to cover liabilities (short term)
Assets: ...... €1 EURO asset to cover short-term debt obligations: ...... €
Liabilities: ...... €Net Working capital: ...... €

BRAVO PHARMACEUTICALS AS

Claims history
?
1 month
6 months
1 year
5 years
MAX
Debt claims as of ......
Tax debt ...... €
Debt claims ...... €

Total debt claims: ...... €


PAYMENT SCHEDULE
......
Latest events
...... ......

BRAVO PHARMACEUTICALS AS

Debt by type 13.06.2024
?
Debt by type
Type of claim Amount of claims In payment schedule Disputed Decider during which the debt was incurred Representative
Tax collector 's claims ...... € ...... € ...... €
Special income tax ...... € ...... € ...... € ETCB
Withholding tax ...... € ...... € ...... € ETCB
Social tax ...... € ...... € ...... € ETCB
Creditors' claims ...... € ...... € ...... €
Total ...... € ...... € ...... €

BRAVO PHARMACEUTICALS AS

Time-barred and ongoing claims as of 13.06.2024
?
Ongoing
Sum:
......
...... €
Time-barred
Sum:
......
...... €

BRAVO PHARMACEUTICALS AS

Income (turnover) and expenditure (taxes paid)
?
QuarterTurnoverTaxed turnoverNational taxes paidLabor taxes paidNumber of employees
2024 I* ...... €...... €...... €...... €......
2023 IV* ...... €...... €...... €...... €......
2023 III* ...... €...... €...... €...... €......
2023 II* ...... €...... €...... €...... €......
2023 I* ...... €...... €...... €...... €......
2022 IV* ...... €...... €...... €...... €......
2022 III* ...... €...... €...... €...... €......
2022 II* ...... €...... €...... €...... €......
2022 I* ...... €...... €...... €...... €......
2021 IV* ...... €...... €...... €...... €......
2021 III* ...... €...... €...... €...... €......
2021 II* ...... €...... €...... €...... €......
2021 I* ...... €...... €...... €...... €......
2020 IV* ...... €...... €...... €...... €......
2020 III* ...... €...... €...... €...... €......
2020 II* ...... €...... €...... €...... €......
2020 I* ...... €...... €...... €...... €......
2019 IV* ...... €...... €...... €...... €......
2019 III* ...... €...... €...... €...... €......
2019 II* ...... €...... €...... €...... €......
2019 I* ...... €...... €...... €...... €......
2018 IV* ...... €...... €...... €...... €......
2018 III* ...... €...... €...... €...... €......
2018 II* ...... €...... €...... €...... €......
2018 I* ...... €...... €...... €...... €......
2017 IV* ...... €...... €...... €...... €......
2017 III* ...... €...... €...... €...... €......
2017 II* ...... €...... €...... €...... €......
2017 I* ...... €...... €...... €...... €......

BRAVO PHARMACEUTICALS AS

Court orders in the register as of 14.06.2024
?

Court order MISSING

BRAVO PHARMACEUTICALS AS

Decisions of the Consumer Disputes Committee as of 14.06.2024
?

Consumer disputes MISSING

BRAVO PHARMACEUTICALS AS

Court hearings as of 14.06.2024
?

Court hearings MISSING

BRAVO PHARMACEUTICALS AS

Rulings as of 14.06.2024
?

Court settlemets MISSING

BRAVO PHARMACEUTICALS AS

Notices and announcements as of 14.06.2024
?
Logo

Notice of delivery of a Tax and Customs Board document

12.06.2024
Maksu- ja Tolliameti dokumendi kättetoimetamise teade
Avaldamise algus: 12.06.2024
Avaldamise lõpp: 13.09.2024
Maksu- ja Tolliamet avaldab teadaande maksukorralduse seaduse (MKS) § 55 alusel.

Menetlusosalisele AS Bravo Pharmaceuticals (registrikood: 14159974) toimetatakse kätte 21.05.2024 korraldus nr 13-11/30970 maksuvõla tasumiseks summas 3 234,22 eurot kümne päeva jooksul korralduse kättetoimetamisest arvates.


Dokumendi resolutiivosa loetakse kättetoimetatuks kümne päeva möödumisel käesoleva teadaande avaldamisest (MKS § 55).
 
Dokumentide terviktekstidega on võimalik tutvuda Maksu- ja Tolliameti lähimas teenindusbüroos.
Maksu- ja Tolliamet
Tallinn, HARJUMAA, Lõõtsa 8a
Telefon: 8800812
E-post: emta@emta.ee
Teadaande number 2268253

Marketing

Business network

BRAVO PHARMACEUTICALS AS

Business network
CREDIT RISK CLASSES
Deleted
Trustworthy
Neutral
Borderline
Problematic
Risky
Historical connection
Active connection
amount of turnover
amount of debt
Extension of networks
The network is visible with reduced links
Expand threads if desired

Beneficiaries network

BRAVO PHARMACEUTICALS AS

Networks - Beneficiaries
The network is visible with reduced links
Expand threads if desired

Monitoring events

Filter

Dropdown

Year

Dropdown

Type

Neutral

Positive

Negative

No monitoring events were found

Failed to load monitoring events